跳至主要内容
临床试验/NCT01370577
NCT01370577已完成不适用

The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly

AstraZeneca1 个研究点 分布在 1 个国家目标入组 297 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
297
试验地点
1
主要终点
Baseline characteristics related to asthma control in the elderly

研究概览

简要总结

The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 60 years or more, articulate in Korean
  • Patients diagnosed with asthma, at least 1 year in duration.

排除标准

  • Patients being followed-up for asthma treatment less than 1 year before baseline
  • Patients taking immune therapy
  • Patients previously enrolled/randomized in the present clinical trial

结局指标

主要结局

Baseline characteristics related to asthma control in the elderly

时间窗: 6 months

Asthma exacerbation rate of the elderly during guideline-based stepwise treatments

时间窗: 6 months

次要结局

  • 1. Proportion of controlled, partially controlled, and controlled patients among the elderly patients with asthma in Korea(6 months)
  • 2. Baseline characteristics related to asthma specific QOL in the elderly patients with asthma(6 months)
  • Mean frequency of PFT, sputum assessments, refill adherence(%), prescription persistence in elderly asthma for the last 1 year before study enrollment(6 months)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验